摘要
摘要 目的：探讨对脑血栓患者选择氯吡格雷 +疏血通注射液治疗后获得的临床效果以及治疗安全性。方法：收治脑血栓患者 50例，采用数字奇偶法分组。对照组 25例选择氯吡格雷进行治疗，观察组 25例选择氯吡格雷 +疏血通注射液进行治疗，最终就两组脑血栓患者用药效果、血流变指标以及用药安全性对比。结果：同对照组脑血栓患者用药效果（ 72.00%）对比，观察组总有效率（ 96.OO%）提升程度显著（ P<0.05） ;同对照组脑血栓患者血流变指标对比，观察组降低程度显著（ P<0.05） ;两组脑血栓患者均未呈现出明显用药反应。结论：医疗人员对于脑血栓患者选择氯吡格雷 +疏血通注射液加以治疗，其用药效果以及用药安全指数均有保障，并且可以将血流变指标显著改善，从而促进脑血栓患者病情康复。
关键词 疏血通注射液 ;氯吡格雷 ;脑血栓 ;临床效果 ;安全性
Objective: To explore the clinical effect and safety of clopidogrel + Shuxuetong injection in the treatment of cerebral thrombosis. Methods: 50 patients with cerebral thrombosis were divided into groups by digital parity. 25 cases in the control group were treated with clopidogrel, and 25 cases in the observation group were treated with clopidogrel + Shuxuetong injection. Finally, the therapeutic effect, hemorheology index and safety of the two groups were compared. Results: compared with the control group (72.00%), the total effective rate of the observation group (96.oo%) increased significantly (P < 0.05); compared with the control group, the hemorheology index of the observation group decreased significantly (P < 0.05); the two groups of cerebral thrombosis patients did not show significant drug response. Conclusion: clopidogrel + Shuxuetong injection is selected by medical staff for the treatment of cerebral thrombus patients, its medication effect and medication safety index are guaranteed, and the hemorheology index can be significantly improved, so as to promote the rehabilitation of cerebral thrombus patients.
出版日期
2019年12月17日（中国期刊网平台首次上网日期，不代表论文的发表时间）
